ClinicalTrials.gg
RecruitingNCT06951568Updated Apr 30, 2025

Study of the Effect of Peripheral Somatosensory Stimulation on the Functionality of Patients With Cerebral Palsy and Reduced Mobility

An interventional study of Physical Exercise Program in Cerebral Palsy, sponsored by Facultat de ciencies de la Salut Universitat Ramon Llull. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-04-30.

Sponsored by Facultat de ciencies de la Salut Universitat Ramon Llull · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Cerebral Palsy with a site in Spain — 14 open to participants now, 17 under way, 1 of them phase 3. Cerebral Palsy · Spain.

Planned enrollment
32nd of 44
20 · median 32
Started
2025
with 6 others
No phase
37 of 54
11 open now
Primary completion
2025-07
later than 10 of 16 live
Registered
49th of 54
by date

Among the 54 studies in Cerebral Palsy with a site in Spain, this one is the 32nd largest by planned enrollment of the 44 interventional ones that give a count, is one of 7 that started in 2025, is one of 37 with no phase, reaches primary completion later than 10 of the 16 other live ones, and was the 49th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

14 of the 54 studies in Cerebral Palsy with a site in Spain are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Cerebral Palsy with a site in Spain, or all of them as a file.
02

Study summary

Cerebral palsy (CP) is a permanent neurological disorder that affects movement and posture, caused by an injury to the developing brain. It may also be accompanied by cognitive, hearing, and speech impairments, as well as epilepsy. Although it is a condition that manifests in childhood, its effects persist throughout life, posing specific challenges in mobility and functionality during adulthood. Although physiotherapy is a key component in the rehabilitation of children with CP and helps adults manage pain and improve motor function, many adults with CP do not receive the treatment they need. Barriers such as financial difficulties, transportation issues, and the lack of physiotherapists specialized in CP affect both access to and the quality of care. Even when physiotherapy is provided, adults with CP are often less satisfied with the services compared to children.The aim of this study is to promote the recovery of motor function in adults with cerebral palsy through sensory stimulation of the lower limbs, as part of an intensive motor rehabilitation program. This program seeks to foster autonomy in movements and transfers, as well as active participation in daily life activities.

Read the detailed description

Objective: To evaluate the impact of peripheral somatosensory stimulation on motor function in adults with cerebral palsy.

Methods: Experimental, crossover, and randomized. Each participant will serve as their own control and will be assessed under both stimulation (experimental) and non-stimulation (control) conditions.The sample will be one of convenience and will consist of the voluntary participation of 20 adults diagnosed with cerebral palsy who have reduced mobility and are institutionalized at the residence of the Catalan Foundation for Cerebral Palsy (FCPC).The physical exercise program will last for 2 days per week over a period of 12 consecutive weeks, with prior agreement from the center's management and their participation in the study. The 20 participants will be divided into two groups of 10 people. The first group (Group A) will begin the intervention with both the physiotherapy protocol and somatosensory stimulation, while the second group (Group B) will start with the physiotherapy protocol only. At the midpoint of the intervention, in week 6, the groups will switch: Group A will then receive only the physiotherapy protocol, and Group B will begin receiving somatosensory stimulation alongside the physiotherapy protocol. Both groups will continue under these conditions until week 12, marking the end of the intervention.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with a medical diagnosis of cerebral palsy
  • Age: 18-50 years
  • Reduced mobility classified as levels I, II, or III according to the GMFCS
  • Ability to participate in functional assessments with the support of the clinical team
  • Ability to understand or have a legal representative who can provide consent on their behalf

Exclusion criteria

Exclusion Criteria

  • Patients with cerebral palsy who have severe cognitive impairments that hinder understanding of instructions or participation in assessments
  • Adults with cerebral palsy who present with medical conditions that may interfere with the intervention, such as severe cardiovascular disease or major neurological disorders
  • Individuals with cerebral palsy who are participating in another intervention study during the same period
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Group Intervention INITIAL

    Group INITIAL will begin the intervention with both the physiotherapy protocol and somatosensory stimulation, At the midpoint of the intervention, in week 6, the groups will switch: Group INITIAL will then receive only the physiotherapy protocol. Both groups will continue under these conditions until week 12, which marks the end of the protocol.

    Other: Physical Exercise Program

  • Active comparator
    Group Intervention CROSSED

    Group CROSSED will start with the physiotherapy protocol only. At the midpoint of the intervention, in week 6, the groups will switch: Group CROSSED will receive somatosensory stimulation alongside physiotherapy. Both groups will continue under these conditions until week 12, which marks the end of the protocol.

    Other: Physical Exercise Program

Interventions

  • OtherPhysical Exercise Program

    The physiotherapy protocol has been developed using the GMFCS scale as a reference. Based on this assessment, each patient's level is determined according to their functional motor abilities, limitations, and use of assistive or mobility devices. Each protocol consists of a total of five exercises: two general exercises and three specific exercises focused on the phases of the corresponding transfer and on skills common to all transfers. Rest periods of 2 minutes and 30 seconds are provided between exercises to ensure adequate recovery and a safe progression. The somatosensory stimulation will consist of intermittent mechanical pressure applied to the skin over the neuromuscular motor points of the quadriceps and gastrocnemius muscles. T

06

What researchers measure

Primary outcomes

  1. Rivermead Mobility Index (RMI)

    To evaluate the level of functional mobility, focusing on tasks such as turning over, walking, and climbing stairs. 0-5 points: severely limited mobility. 6-10 points: moderately limited mobility. 11-15 points: mildly limited or good functional mobility.

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

Secondary outcomes

  1. the Trunk Impairment Scale.

    To analyze trunk postural control 0 points: complete absence of trunk control. 1-7 points: severely impaired trunk control. 8-15 points: moderately impaired trunk control. 16-23 points: good trunk control (mild impairment or normal function).

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

  2. number of repetitions

    To evaluate the number of repetitions in the specific exercises of the protocol

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

  3. The time taken to perform the movement

    time required for execution and the completeness of the performance.

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

07

Study locations

1 of 1 sites recruiting
  • Pedro Victor López Plaza
    Barcelona, Spain
    Recruiting
    • Pedro V López · Contactpedrovictorlp@blanuqerna.url.edu · 932 53 32 56
    • Pedro Victor López Plaza · Principal investigator
    • Marta Cuadros · Sub investigator
    • Lorenzo Escutia · Sub investigator
    • Ismael Ordoñez · Sub investigator
    • Jessica Zamora · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2025; primary completion for Jul 2025, 2 months later.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 2 months is below that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 20, 2025
First posted
Apr 30, 2025
StartEst.
May 2, 2025
Primary completionEst.
Jul 2, 2025
CompletionEst.
Sep 30, 2025
Last update
Apr 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06951568
Lead sponsor
Facultat de ciencies de la Salut Universitat Ramon Llull
Collaborators
Cerebral Palsy Association
Responsible party
Sponsor
First posted
Apr 30, 2025
Start date
May 2, 2025 (estimated)
Primary completion
Jul 2, 2025 (estimated)
Completion
Sep 30, 2025 (estimated)
Last update
Apr 30, 2025

Study contacts

Pedro V López Plaza, Director
Contact
pedrovictorlp@gmail.com
932 53 32 56

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion